Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Phase 3: Maintenance (Weeks 912) Dose: 3.2 mg, 2-3x per week Pulsed administration keeps the repair signal present without turning the protocol into constant stimulation
What the evidence supports: BPC-157 consistently improves tendon healing outcomes in animal models across multiple tissue types and injury models TB-500 accelerates wound healing and tissue repair in preclinical studies with measurable improvements in re-epithelialization, collagen deposition, and angiogenesis GHK-Cu enhances collagen synthesis and modulates thousands of genes involved in tissue repair GHRP-2 shifts macrophage polarization favorably in a rotator cuff tear model Relaxin-2 eliminates capsular fibrosis in a frozen shoulder mouse model No significant toxicity has been identified in preclinical BPC-157 studies What remains uncertain: Whether animal study results translate to equivalent human outcomes for shoulder conditions specifically Optimal dosing for human shoulder injuries (all protocols are extrapolated from animal data and clinical observation) Long-term safety with repeated use Whether peptides meaningfully reduce rotator cuff retear rates after surgical repair in humans How peptide therapy compares to established treatments like PRP in controlled human studies Potential interactions with medications commonly used by shoulder pain patients What we need: Randomized controlled trials of BPC-157 and TB-500 for specific shoulder conditions in humans Head-to-head comparisons of peptide therapy versus established treatments Long-term safety data from monitored human use Standardized dosing protocols based on human pharmacokinetic data Studies combining peptides with rehabilitation to assess synergistic effects The preclinical evidence is compelling
We utilize the most appropriate and scientifically advanced analytical techniques, along with a well-designed quality control system, to develop the finest-quality supplements
Various versions of HT have been reported with various HLA alleles, including DR3, DR5, DQ7, DQB1*03, DQw7, or the DRB1*04-DQB1*0301 haplotype
You will find plenty of scientific studies into the ingredients of this antioxidant supplement, alongside anecdotal evidence
If, indeed, you appear to have leaky gut, L-glutamine is the No
